Icosavax, Inc.
NASDAQ:ICVX
15.31 (USD) • At close February 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Operating Activities: | ||||
Net Income
| -91.758 | -66.971 | -18.854 | -5.297 |
Depreciation & Amortization
| 0.86 | 0.082 | 0.001 | 0 |
Deferred Income Tax
| 0 | 0.959 | -0.187 | 0 |
Stock Based Compensation
| 21.694 | 29.031 | 0.257 | 0.072 |
Change In Working Capital
| 8.074 | -1.905 | 4.158 | 0.656 |
Accounts Receivables
| 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 |
Accounts Payables
| -1.195 | 1.839 | 1.119 | 0.452 |
Other Working Capital
| 9.269 | -3.744 | 3.039 | 0.204 |
Other Non Cash Items
| -0.545 | 0.264 | 0.417 | 0 |
Operating Cash Flow
| -61.675 | -38.54 | -14.208 | -4.569 |
Investing Activities: | ||||
Investments In Property Plant And Equipment
| -11.113 | -1.006 | -0.011 | 0 |
Acquisitions Net
| 158.336 | 0 | 0 | 0 |
Purchases Of Investments
| -221.086 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 62.75 | 0 | 0 | 0 |
Other Investing Activites
| -158.336 | 0 | 0 | 0 |
Investing Cash Flow
| -169.449 | -1.006 | -0.011 | 0 |
Financing Activities: | ||||
Debt Repayment
| 0 | 0 | -6.464 | 0 |
Common Stock Issued
| 0 | 190.738 | 0.174 | 26.742 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 |
Other Financing Activities
| 10.307 | 114.034 | 12.928 | 0 |
Financing Cash Flow
| 10.307 | 304.772 | 6.638 | 26.742 |
Other Information: | ||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 |
Net Change In Cash
| -220.817 | 265.226 | -7.581 | 22.173 |
Cash At End Of Period
| 59.907 | 280.724 | 15.498 | 23.079 |